Visit Nervana Neurospa and Nervana Neurology & Wellness at our new Brooklyn location!
Visit Nervana Neurospa and Nervana Neurology & Wellness at our new Brooklyn location!
The U.S. Food and Drug Administration just approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. It is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.